Gastric cancer. Malignant neoplasm of stomach
Conditions
Interventions
Intervention 1: Intervention group will be administrated Captopril. Intervention 2: Control group will be received placebo (starch pill).
Treatment - Drugs
Placebo
Intervention group will be administrated Captopril
Control group will be received placebo (starch pill)
Sponsors
Shiraz University of Midical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Patients with aged 40-80 years old; Patients with BMI less 18 and those with muscle wasting or only temporal wasting. Exclusion Criteria: Patients unable to continue the treatment; Patients with BMI more 18 without temporal or muscle wasting; Those with GFR less 50 ml/min; Positive history of other co-morbidity diseases; Patients with Hb less 9; Patients unavailable for or incapable of filling out questionnaires at different intervals.
Exclusion criteria
Exclusion criteria:
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Body Mass Index. Timepoint: Bfore and 1 month and 2 months after intervention. Method of measurement: By BMI Formula. | — |
Primary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: Before and 1 month and 2 months after intervention. Method of measurement: QLQ-C30 questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Mehdi Mirzaei
Shiraz University of Medical Sciences
Outcome results
None listed